Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation

AJ Kombe Kombe, B Li, A Zahid, HM Mengist… - Frontiers in public …, 2021 - frontiersin.org
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women,
human papillomavirus (HPV) is currently the most common pathogen responsible for female …

Cervical cancer prevention and control in women living with human immunodeficiency virus

PE Castle, MH Einstein… - CA: a cancer journal for …, 2021 - Wiley Online Library
Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …

[HTML][HTML] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

M Arbyn, E Weiderpass, L Bruni… - The Lancet Global …, 2020 - thelancet.com
Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income …

M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras… - The Lancet, 2020 - thelancet.com
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Efficacy of single-dose human papillomavirus vaccination among young African women

RV Barnabas, ER Brown, MA Onono, EA Bukusi… - NEJM …, 2022 - evidence.nejm.org
Background Single-dose human papillomavirus (HPV) vaccination, if efficacious, would be
tremendously advantageous, simplifying implementation and decreasing costs. Methods We …

Human papillomavirus vaccine efficacy and effectiveness against cancer

S Kamolratanakul, P Pitisuttithum - Vaccines, 2021 - mdpi.com
Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

K Canfell, JJ Kim, M Brisson, A Keane, KT Simms… - The Lancet, 2020 - thelancet.com
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Cervical cancer immunotherapy: facts and hopes

L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu - Clinical Cancer Research, 2021 - AACR
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Real-world effectiveness of human papillomavirus vaccination against cervical cancer

SK Kjaer, C Dehlendorff, F Belmonte… - JNCI: Journal of the …, 2021 - academic.oup.com
Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

[HTML][HTML] Human papillomavirus vaccine against cervical cancer: Opportunity and challenge

R Wang, W Pan, L Jin, W Huang, Y Li, D Wu, C Gao… - Cancer letters, 2020 - Elsevier
Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …